← Chlorpheniramine 1 mg/Promethazine 2.5 mg /Diphenhydramine 5 mg/Ammonium Chloride 90 mg/5ml

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Chlorpheniramine 1 mg/Promethazine 2.5 mg /Diphenhydramine 5 mg/Ammonium Chloride 90 mg/5ml

Therapeutic agent (verify pharmacological class)

Prepared 24 Sep 2026

What it is used for

Uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies: sneezing runny nose itching of the nose or throat itchy, watery eyes Clinical selection for Chlorpheniramine 1 mg/Promethazine 2.5 mg /Diphenhydramine 5 mg/Ammonium Chloride 90 mg/5ml should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Warnings Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland

Possible side effects

[From component Chlorpheniramine] Drowsiness; psychomotor impairment; anti-muscarinic effects [e.g. urinary retention; dry mouth; GI disturbances; blurred vision]; allergic reactions; epileptic form seizure in patients with cerebral cortex focal lesion; muscle weakness; tachycardia; tight chest; paradoxical CNS stimulation - mostly in children.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage